Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16


Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole.

Frankel JS, Schwartz TL.

Ther Adv Psychopharmacol. 2017 Jan;7(1):29-41. doi: 10.1177/2045125316672136. Epub 2016 Oct 17. Review.


The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ.

Int J Neuropsychopharmacol. 2016 Dec 22. pii: pyw100. doi: 10.1093/ijnp/pyw100. [Epub ahead of print] Review.


The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review.

Muneer A.

Cureus. 2016 Apr 7;8(4):e562. doi: 10.7759/cureus.562. Review.


Aripiprazole: from pharmacological profile to clinical use.

Di Sciascio G, Riva MA.

Neuropsychiatr Dis Treat. 2015 Oct 13;11:2635-47. doi: 10.2147/NDT.S88117. eCollection 2015. Review.


Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study.

Bourin MS, Severus E, Schronen JP, Gass P, Szamosi J, Eriksson H, Chandrashekar H.

Int J Bipolar Disord. 2014 Nov 8;2:14. doi: 10.1186/s40345-014-0014-9. eCollection 2014.


When to start aripiprazole therapy in patients with bipolar mania.

Sayyaparaju KK, Grunze H, Fountoulakis KN.

Neuropsychiatr Dis Treat. 2014 Mar 13;10:459-70. doi: 10.2147/NDT.S40066. eCollection 2014. Review.


A Chromatographic Determination of Aripiprazole using HPLC and UPLC: A Comparative Validation Study.

Thakkar RS, Saravaia HT, Ambasana MA, Kaila HO, Shah AK.

Indian J Pharm Sci. 2011 Jul;73(4):439-43. doi: 10.4103/0250-474X.95638.


Aripiprazole in the acute and maintenance phase of bipolar I disorder.

Zupancic M, Gonzalez ML.

Ther Clin Risk Manag. 2012;8:1-6. doi: 10.2147/TCRM.S22579. Epub 2012 Jan 12.


Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence.

McIntyre RS, Yoon J, Jerrell JM, Liauw SS.

Neuropsychiatr Dis Treat. 2011;7:319-23. doi: 10.2147/NDT.S13876. Epub 2011 May 25.


Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?

Fountoulakis KN, Gonda X, Vieta E, Rihmer Z.

Ann Gen Psychiatry. 2011 Mar 24;10(1):8. doi: 10.1186/1744-859X-10-8.


Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163).

Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Van Tran Q, Pikalov A, Qi Y, Carlson BX, Marcus RN, Berman RM.

Prim Care Companion J Clin Psychiatry. 2009;11(6):344-52. doi: 10.4088/PCC.08m00744gre.


Treating bipolar disorder in the primary care setting: the role of aripiprazole.

Manning JS, McElroy SL.

Prim Care Companion J Clin Psychiatry. 2009;11(5):245-57. doi: 10.4088/PCC.08r00635.


Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.

Fountoulakis KN, Vieta E.

Ann Gen Psychiatry. 2009 Jul 27;8:16. doi: 10.1186/1744-859X-8-16.


Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole.

Muzina DJ.

Neuropsychiatr Dis Treat. 2009;5:279-88. Epub 2009 May 20.


Easing the burden of bipolar disorder: from urgent situations to remission.

[No authors listed]

Prim Care Companion J Clin Psychiatry. 2008;10(5):391-402. No abstract available.

Supplemental Content

Support Center